Literature DB >> 11110377

Postoperative radiotherapy for canine soft tissue sarcoma.

L J Forrest1, R Chun, W M Adams, A J Cooley, D M Vail.   

Abstract

Thirty-five dogs with 37 soft tissue sarcoma tumors that were incompletely excised and treated with radiotherapy in the postoperative, adjuvant setting were reviewed. Variables evaluated included age, sex, tumor site, tumor histology, total tumor radiation dose, radiotherapy field size. time to recurrence, and survival. The majority of tumors were fibrosarcomas and hemangiopericytomas, but small numbers of other tumor types were also represented. Total tumor radiation dose ranged from 42 to 57 Gy given in 3- to 4.2-Gy daily fractions on a Monday through Friday schedule. Overall median survival was 1,851 days. Median time to local recurrence was greater than 798 days. Soft-tissue sarcoma tumors at oral sites had a statistically significant lower median survival (540 days) as compared to other tumor sites (2,270 days). Radiotherapy may be a useful adjuvant therapy for incompletely excised soft-tissue sarcomas with a reasonable expectation for long-term patient survival.

Entities:  

Mesh:

Year:  2000        PMID: 11110377     DOI: 10.1892/0891-6640(2000)014<0578:prfcst>2.3.co;2

Source DB:  PubMed          Journal:  J Vet Intern Med        ISSN: 0891-6640            Impact factor:   3.333


  11 in total

1.  Diagnosis and treatment of a periocular myxosarcoma in a bearded dragon (Pogona vitticeps).

Authors:  Sara Gardhouse; David Eshar; Bridget Lee-Chow; Robert A Foster; Joelle C Ingrao; Valerie J Poirier
Journal:  Can Vet J       Date:  2014-07       Impact factor: 1.008

2.  Preclinical Validation of the Utility of BLZ-100 in Providing Fluorescence Contrast for Imaging Spontaneous Solid Tumors.

Authors:  Janean Fidel; Katie C Kennedy; William S Dernell; Stacey Hansen; Valorie Wiss; Mark R Stroud; Joshua I Molho; Sue E Knoblaugh; Jeffrey Meganck; James M Olson; Brad Rice; Julia Parrish-Novak
Journal:  Cancer Res       Date:  2015-10-15       Impact factor: 12.701

3.  3D printing for surgical planning of canine oral and maxillofacial surgeries.

Authors:  Yu-Hui Huang; Bonnie Lee; Jeffrey A Chuy; Stephanie L Goldschmidt
Journal:  3D Print Med       Date:  2022-06-09

Review 4.  Canine sarcomas as a surrogate for the human disease.

Authors:  Daniel L Gustafson; Dawn L Duval; Daniel P Regan; Douglas H Thamm
Journal:  Pharmacol Ther       Date:  2018-03-09       Impact factor: 12.310

5.  Preclinical evaluation of oncolytic vaccinia virus for therapy of canine soft tissue sarcoma.

Authors:  Ivaylo Gentschev; Marion Adelfinger; Rafael Josupeit; Stephan Rudolph; Klaas Ehrig; Ulrike Donat; Stephanie Weibel; Nanhai G Chen; Yong A Yu; Qian Zhang; Martin Heisig; Douglas Thamm; Jochen Stritzker; Amy Macneill; Aladar A Szalay
Journal:  PLoS One       Date:  2012-05-15       Impact factor: 3.240

6.  Outcomes of Spatially Fractionated Radiotherapy (GRID) for Bulky Soft Tissue Sarcomas in a Large Animal Model.

Authors:  Michael W Nolan; Tracy L Gieger; Alexander A Karakashian; Mariana N Nikolova-Karakashian; Lysa P Posner; Donald M Roback; Judith N Rivera; Sha Chang
Journal:  Technol Cancer Res Treat       Date:  2017-02-07

7.  Adjuvant electrochemotherapy with bleomycin and cisplatin combination for canine soft tissue sarcomas: A study of 30 cases.

Authors:  Enrico P Spugnini; Bruno Vincenzi; Bruno Amadio; Alfonso Baldi
Journal:  Open Vet J       Date:  2019-03-25

8.  Mediastinal Fibrosarcoma in a Dog-Case Report.

Authors:  Alysha M McGrath; Sarah A Salyer; Amanda Seelmann; Alycen P Lundberg; Melissa R Leonard; Joshua N Lorbach; Sarah Lumbrezer-Johnson; Eric T Hostnik; Giovanni Tremolada; Janis Lapsley; Laura E Selmic
Journal:  Front Vet Sci       Date:  2022-02-09

9.  Canine Soft Tissue Sarcomas: Can Being a Dog's Best Friend Help a Child?

Authors:  Bernard Séguin
Journal:  Front Oncol       Date:  2017-11-23       Impact factor: 6.244

10.  Direct Interstitial Treatment of Solid Tumors Using an Injectable Yttrium-90-Polymer Composite.

Authors:  Darrell R Fisher; Janean Fidel; Charles A Maitz
Journal:  Cancer Biother Radiopharm       Date:  2019-10-17       Impact factor: 3.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.